Back to results
US 6,884,439 B2Granted
Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
AssigneeMemorial Sloan Kettering Cancer Center
InventorsRaymond P. Warrell, Jr., Pier Paolo Pandolfi, Janice L. Gabrilove
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
Claims21
A method for treating acute promyelocytic leukemia in a human comprising administering a therapeutically effective dosage amount of about 0.15 mg/kg arsenic trioxide once per day.
Dependencies are inferred from the claim text.